Precision-Based Sample Size Determination: Implications for Decision-Making.

Authors

Jiwei He, Taekwon Hong, Andrew Giffin, Rongmei Zhang, Yong Ma

Published in

Therapeutic innovation & regulatory science. Aug 30, 2026. Epub Aug 30, 2026.

Abstract

Power-based sample size calculation is the standard approach in confirmatory clinical trials, where adequate statistical power is essential for study success. In other decision-making contexts, however, a precision-based approach to sample size determination is sometimes adopted. One such area is consumer studies that evaluate consumers' ability to appropriately select nonprescription medications. Compared with power-based designs, precision-based approaches typically require fewer study participants and can therefore reduce study costs. However, the extent of loss in statistical power has not been well quantified. In this paper, we evaluate the statistical power of precision-based sample size determination and illustrate its practical implementation. Our analysis demonstrates that when the target precision is set to the difference between the expected proportion and the null threshold, the resulting design achieves only approximately 50% power. This underpowering is further exacerbated when normal approximation is used for sample size determination, commonly practiced for convenience, but exact methods are used for analysis. For studies that plan to use a precision-based approach to support hypothesis testing in decision-making contexts, it is important to be aware of the potential underpower issue in this approach.

PMID:
42669109
Bibliographic data and abstract were imported from PubMed on 31 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.